ECSP024356A - Formulaciones estables liquidas y solidas - Google Patents

Formulaciones estables liquidas y solidas

Info

Publication number
ECSP024356A
ECSP024356A EC2002004356A ECSP024356A ECSP024356A EC SP024356 A ECSP024356 A EC SP024356A EC 2002004356 A EC2002004356 A EC 2002004356A EC SP024356 A ECSP024356 A EC SP024356A EC SP024356 A ECSP024356 A EC SP024356A
Authority
EC
Ecuador
Prior art keywords
solid
stable formulations
stable
formulations liquid
liquid
Prior art date
Application number
EC2002004356A
Other languages
English (en)
Inventor
Lugo Sergio Rolando Ulloa
Ramos Jose De Jesus Villacampa
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2000/005129A external-priority patent/MXPA00005129A/es
Application filed by Schering Corp filed Critical Schering Corp
Publication of ECSP024356A publication Critical patent/ECSP024356A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Se describen composiciones farmacéuticas estables que contienen antihistaminas no sedantes y un descongestionante nasal como sulfato de pseudoefedrina y por lo menos un vehículo aceptable para uso farmacéutico que sean estables a la degradación física y química y a la contaminación por microbios.
EC2002004356A 2000-05-25 2002-11-22 Formulaciones estables liquidas y solidas ECSP024356A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MXPA/A/2000/005129A MXPA00005129A (es) 2000-05-24 Composiciones farmaceuticas antihistaminicas - anticongestivas liquidas estables

Publications (1)

Publication Number Publication Date
ECSP024356A true ECSP024356A (es) 2003-03-31

Family

ID=33308448

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2002004356A ECSP024356A (es) 2000-05-25 2002-11-22 Formulaciones estables liquidas y solidas

Country Status (7)

Country Link
AU (1) AU2001264806A1 (es)
BR (1) BR0111018A (es)
CR (1) CR6804A (es)
EC (1) ECSP024356A (es)
PA (1) PA8517201A1 (es)
PE (1) PE20020055A1 (es)
WO (1) WO2001089527A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6635654B1 (en) 2003-01-09 2003-10-21 Allergan, Inc. Ophthalmic compositions containing loratadine
AU2005333081B2 (en) 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
SG173333A1 (en) * 2006-06-29 2011-08-29 Schering Corp Sugar-free storage-stable antihistaminic syrups
WO2022159763A1 (en) * 2021-01-22 2022-07-28 Model Medicines, Inc. Sars-cov-2 therapeutics
CN116898799B (zh) * 2023-08-30 2024-04-30 哈尔滨圣泰生物制药有限公司 一种地氯雷他定口服制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
CN1130354A (zh) * 1993-09-07 1996-09-04 普罗克特和廿保尔公司 含有丙酸类非甾体消炎药氨基酸盐和减充血药、祛痰药、抗组胺药和镇咳药中至少一种的组合物
EP0941091A1 (en) * 1996-10-31 1999-09-15 Schering Corporation Composition, for the treatment of asthma, containing loratadine and a decongestant
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
US6051585A (en) * 1998-12-07 2000-04-18 Weinstein; Robert E. Single-dose antihistamine/decongestant formulations for treating rhinitis
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤

Also Published As

Publication number Publication date
AU2001264806A1 (en) 2001-12-03
WO2001089527A3 (en) 2003-10-16
CR6804A (es) 2008-10-29
PA8517201A1 (es) 2002-08-26
PE20020055A1 (es) 2002-02-12
WO2001089527A2 (en) 2001-11-29
BR0111018A (pt) 2004-02-17

Similar Documents

Publication Publication Date Title
ATE253896T1 (de) Zwei oder mehrere wirkstoffe enthaltende pharmazeutische aerosolformulierungen
AU2001244614A1 (en) Oily compositions containing highly fat-soluble drugs
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
DE69819338D1 (de) Lipid haltige zusammenstellungen und deren verwendungen
DE60335557D1 (de) Pharmazeutische zusammensetzungen enthaltend ein opioidanalgetikum
WO2003002136A3 (en) Stable formulation of modified glp-1
AU2002335046A1 (en) The use of proton sequestering agents in drug formulations
ATE332918T1 (de) Neoglycoproteine
ATE554750T1 (de) Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen
DZ2516A1 (fr) Composition pharmaceutique en aérosol.
AT7729U3 (de) Pharmazeutische zusammensetzungen enthaltend amlodipinmaleat
DK1104425T3 (da) Hidtil ukendte thiazolopyrimidinforbindelser
AU2001234114A1 (en) Drugs containing combined active ingredients
CA2352915A1 (en) Pharmaceutical compositions containing mupirocin
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
AU3868997A (en) Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
CR6804A (es) Formulaciones estables, liquidas y solidas
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ATE332140T1 (de) Pharmazeutische zusammensetzungen, welche steroidische strukturen enthalten, und deren verwendungen
AR040764A1 (es) Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina
ITFI970072A0 (it) Composti pseudo-peptidici, loro preparazione ed uso in formulazioni farmaceutiche
ATE424813T1 (de) Pharmazeutische zusammensetzungen mit epinastin und pseudoephedrin
UY26510A1 (es) " biblioteca de sustancias, procedimiento para su preparación y el uso de esta biblioteca de sustancias para la investigación de sustancias activas."
AU2001274251A1 (en) Novel pharmaceutical formulation suitable for nebulisation